Introduction There are an estimated 2.5 million people in the UK living with and beyond cancer and this number is predicted to rise to 4 million by 2030. Many people living with cancer (PLWC) experience long-lasting adverse effects of their disease and treatment (Macmillan Cancer Support, 2011). There is evidence of physical activity showing a positive effect on physical fitness, strength, body composition, quality of life, anxiety and self-esteem as well as decreasing fatigue for PLWC (Speck et al., 2010; Thomas et al., 2014). Physical activity is also associated with increased survival and reduced risk of recurrence for some types of cancer (Leitzmann et al., 2015). Despite this evidence physical activity is still not prescribed to PLWC as part of routine cancer care. Macmillan Cancer Support and Sport Aberdeen entered a partnership to deliver the Move More Aberdeen (MMA) exercise referral programme for PLWC. Aims To provide an analysis of MMA data collected between January 2015 and August 2017 and to evaluate to what extent MMA has supported PLWC into a lifestyle of long-term, independent physical activity for health. Methods A referral pathway for MMA was established in partnership with NHS Grampian. MMA delivery started in January 2015 with 12-week community-based physical activity groups of moderate-intensity (chair-based exercise, walking and gardening) and high-intensity (circuits), delivered using a person-centred motivational interviewing approach that meets the needs of PLWC. The cancer and physical activity standard evaluation framework (CaPASEF) (Macmillan Cancer Support, 2013) was used to measure physical activity levels, self-assessment of health, fatigue, mobility and self-efficacy at baseline, 3, 6 and 12 months. PLWC who completed the MMA programme 12 months ago (n=62) were interviewed in January 2017 to assess long-term adherence to physical activity. Results MMA has generated 326 referrals to date, 65% from NHS health professionals and 35% from self-referrals. Referrals are highest for prostate (25%), breast (24%), bowel (9%), Non-Hodgkin’s lymphoma (7%) and lung (5%) cancer. 64% of PLWC referred to MMA have attended one or more MMA activities. MMA has demonstrated a significant long-term increase in physical activity levels (P<0.01), decrease in fatigue (P<0.05) and improvement in quality of life (P<0.05) for participants. The service evaluation in January 2017 showed that 87% of participants (n=54) had increased or maintained their activity levels 12 months after completing MMA, demonstrating a long-term impact of MMA on physical activity for health. Conclusion MMA has improved access and adherence to physical activity for PLWC and demonstrates a feasible model for integrating physical activity into standard cancer care. Learning from MMA may be used to further implement exercise referral for PLWC in the UK.